These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 952262)

  • 1. Effect of amiodarone in the Wolff-Parkinson-White syndrome.
    Wellens HJ; Lie KI; Bär FW; Wesdorp JC; Dohmen HJ; Düren DR; Durrer D
    Am J Cardiol; 1976 Aug; 38(2):189-94. PubMed ID: 952262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of amiodarone studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia.
    Waleffe A; Bruninx P; Kulbertus HE
    J Electrocardiol; 1978 Jul; 11(3):253-60. PubMed ID: 308527
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous amiodarone in the acute termination of supraventricular arrhythmias.
    Holt P; Crick JC; Davies DW; Curry P
    Int J Cardiol; 1985 May; 8(1):67-79. PubMed ID: 3997293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiologic effects of amiodarone in tachyarrhythmias.
    Liu PH; Lin CC; Ko GC; Wang DJ; Shieh SM; Sung PK
    Taiwan Yi Xue Hui Za Zhi; 1985 Jul; 84(7):759-75. PubMed ID: 3864917
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of an accessory atrioventricular pathway in reciprocal tachycardia. Observations in patients with and without the Wolff-Parkinson-White syndrome.
    Wellens HJ; Durrer D
    Circulation; 1975 Jul; 52(1):58-72. PubMed ID: 1132122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral amiodarone on rate-dependent changes in refractoriness in patients with Wolff-Parkinson-White syndrome.
    Brugada P; Wellens HJ
    Am J Cardiol; 1985 Nov; 56(13):863-6. PubMed ID: 4061328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant ventricular arrhythmia in the Wolff-Parkinson-White syndrome during amiodarone treatment.
    Perticone F; Cuda G; Spadea F; Pintaudi C; Tropea R
    Clin Cardiol; 1987 Aug; 10(8):477-80. PubMed ID: 3621696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of isoproterenol and amiodarone and the role of exercise in initiation of circus movement tachycardia in the accessory atrioventricular pathway.
    Brugada P; Facchini M; Wellens HJ
    Am J Cardiol; 1986 Jan; 57(1):146-9. PubMed ID: 3942059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and electrophysiologic effects of amiodarone in patients with atrial fibrillation complicating the Wolff-Parkinson-White syndrome.
    Feld GK; Nademanee K; Stevenson W; Weiss J; Klitzner T; Singh BN
    Am Heart J; 1988 Jan; 115(1 Pt 1):102-7. PubMed ID: 3336964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Electrophysiologic effects of amiodarone in Wolf-Parkinson-White syndrome].
    Touboul P; Porte J; Huerta F; Delahaye JP
    Arch Mal Coeur Vaiss; 1976 Aug; 69(8):855-63. PubMed ID: 823923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of amiodarone in the Wolff-Parkinson-White syndrome. A clinical and electrophysiological study.
    Rasmussen V; Berning J
    Acta Med Scand; 1979; 205(1-2):31-7. PubMed ID: 367085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of disopyramide on electrophysiological properties of specialized conduction system in man and on accessory atrioventricular pathway in Wolff-Parkinson-White syndrome.
    Spurrell RA; Thorburn CW; Camm J; Sowton E; Deuchar DC
    Br Heart J; 1975 Aug; 37(8):861-7. PubMed ID: 53057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sotalol in supraventricular tachycardia. Electrophysiologic measurements in Wolff-Parkinson-White syndrome and AV node re-entry tachycardia].
    Manz M; Kuhl AJ; Lüderitz B
    Z Kardiol; 1985 Sep; 74(9):500-5. PubMed ID: 4060827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation in patients with an accessory pathway: importance of the conduction properties of the accessory pathway.
    Della Bella P; Brugada P; Talajic M; Lemery R; Torner P; Lezaun R; Dugernier T; Wellens HJ
    J Am Coll Cardiol; 1991 May; 17(6):1352-6. PubMed ID: 2016453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of flecainide acetate in rapid atrial fibrillation complicating Wolff-Parkinson-White syndrome.
    Kappenberger LJ; Fromer MA; Shenasa M; Gloor HO
    Clin Cardiol; 1985 Jun; 8(6):321-6. PubMed ID: 4006340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
    Ludmer PL; McGowan NE; Antman EM; Friedman PL
    J Am Coll Cardiol; 1987 Jun; 9(6):1357-63. PubMed ID: 3294970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wolff-Parkinson-White syndrome and atrial fibrillation. Relation between refractory period of accessory pathway and ventricular rate during atrial fibrillation.
    Wellens HJ; Durrer D
    Am J Cardiol; 1974 Dec; 34(7):777-82. PubMed ID: 4432808
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of intravenous diltiazem administration in patients with inducible tachycardia.
    Waleffe A; Hastir F; Kulbertus HE
    Eur Heart J; 1985 Oct; 6(10):882-90. PubMed ID: 4076199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of amiodarone on atrio-ventricular and ventriculo-atrial conduction in the Wolff-Parkinson-White syndrome (author's transl)].
    Disertori M; Molinis G; Vergara G; Bettini R; Furlanello F
    G Ital Cardiol; 1976; 6(5):792-802. PubMed ID: 1010214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrioventricular nodal reentry in the Wolff-Parkinson-White syndrome.
    Mandel WJ; Laks MM; Obayashi K
    Chest; 1975 Sep; 68(3):321-5. PubMed ID: 1157536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.